Effect of iron chelators on proliferation and iron uptake in hepatoma cells

Cancer

Volumn 92, Issue 12, 2001, Pages 3093-3110

  Kicic, Anthony ^a   Chua, Anita C G ^a   Baker, Erica ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antineoplastic agents; Chemotherapy; Fe metabolism; Hepatocellular carcinoma (HCC); Iron (Fe) chelators

Indexed keywords

ANTINEOPLASTIC AGENT; BIPYRIDINE; DEFERIPRONE; DEFEROXAMINE MESYLATE; EDETIC ACID; IRON; IRON CHELATING AGENT; PENTETIC ACID; PYRIDOXAL ISONICOTINOYLHYDRAZONE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CYCLE; CELL PROLIFERATION; DRUG MECHANISM; HEPATOMA CELL; HUMAN; HUMAN CELL; IRON CHELATION; IRON METABOLISM; IRON TRANSPORT; LIVER CELL CARCINOMA; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL MEMBRANE; DEFEROXAMINE; HUMANS; IRON; IRON CHELATING AGENTS; LIVER NEOPLASMS; PERMEABILITY; TUMOR CELLS, CULTURED;

EID: 0035892992     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011215)92:12<3093::AID-CNCR10107>3.0.CO;2-B     Document Type: Article

References (49)

1. Cancer and infection, estimates of the attributable fraction in 1990
2. Epidemiology of hepatocellular carcinoma
3. Hepatocellular carcinoma
4. Hepatocellular carcinoma
5. Hepatocellular carcinoma
6. Personal experience with 411 hepatic resections
7. Deferoxamine inhibition of human neuroblastoma viability and proliferation
8. Antineuroblastoma activity of desferrioxamine in human cell lines
9. Effects of a single course of deferoxamine in neuroblastoma patients
10. Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): A new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma
11. D-CEaT: A breakthrough for patients with neuroblastoma
12. Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: Preliminary results
13. In vitro and in vivo effects of deferoxamine in neonatal acute leukemia
14. Prospects for oral iron chelation therapy
15. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: The effect of transferrin concentration, chelators and metabolic probes on transferrin and iron uptake
16. The effect of the iron (III) chelator, desferrioxamine in iron and transferrin uptake by the human malignant melanoma cell
17. Desferrioxamine as a purging agent for autologous bone marrow grafts in neuroblastoma
18. Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines
19. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents
20. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone
21. Tumor cell cytotoxicity of a novel metal chelator
22. Relation of oxygenation and temperature in preservation of tissues by refrigeration
23. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents
24. Evaluation of the iron chelation potential of hydrazones of pyridoxal, salicylaldedyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture
25. A comparative study of chemically and enzymatically radio-labelled transferrin
26. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
27. Mechanism of antineuroblastoma activity of deferoxamine in vitro
28. Proliferation-dependent cytotoxicity of diethylenetriaminepentaacetate (DTPA) in vitro
29. Iron at the cell surface controls DNA synthesis in CCL 39 cells
30. The effect of chelating agents on cellular iron metabolism
31. Properties of EDTA, DTPA and HEDTA.
32. Iron reverses impermeable chelator inhibition of DNA synthesis in CCL 39 cells
33. Iron chelators hydroxyurea and bathophenanthroline disulfonate inhibit DNA synthesis by different pathways
34. Inhibition of DNA synthesis in CCL 39 cells by impermeable iron chelators
35. Transplasmamembrane redox systems in growth and development
36. 2transferrin reductase and iron uptake in K562 cells are not directly related
37. Iron supply and cell growth control
38. Stimulation of serum-free cell proliferation by coenzyme Q
39. Bipyridine-induced synthesis of lactate dehydrogenase and aldolase
40. α,α′-Dipyridyl as an antineoplastic agent
41. The reticulocyte plasma membrane pathway of iron uptake as determined by the mechanisms of αα-dipyridyl inhibition
42. A study of iron transfer from rabbit transferrin to reticulocytes using synthetic chelating agents
43. Failure of a cell-free system from rabbit reticulocytes to remove iron from transferrin
44. Effect of iron chelators on the transferrin receptor in K562 cells
45. Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators
46. Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte
47. Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture